United States  

Trusted News Discovery Since 2008
One News Page
One News Page United States > In the News > Johnson & Johnson Facts and News Updates

Johnson & Johnson

U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

Johnson & Johnson    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Johnson & Johnson: U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceutical and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 37 on the 2018 Fortune 500 list of the largest United States corporations by total revenue. J&J is one of the world's most valuable companies.

0
shares
ShareTweetSavePostSend
 

Johnson & Johnson partners with U.S. agency to develop coronavirus vaccine

Johnson & Johnson said on Tuesday it was working with the Biomedical Advanced Research and Development Authority (BARDA) to speed up development of a coronavirus vaccine.
Reuters - Published

Does baby powder cause cancer? A jury ordered Johnson & Johnson to pay $750 million

Is baby powder really safe? The Food and Drug Administration is trying to answer that question about talc, which is similar in structure to asbestos.
USATODAY.com - Published

Videos for Johnson & Johnson


Drugmakers see long road ahead in coronavirus vaccine race [Video]Drugmakers see long road ahead in coronavirus vaccine race

Drugmakers racing to find a vaccine or effective treatment for the deadly new coronavirus in China cautioned that they have a long way to go. Yahaira Jacquez has more.

Credit: Reuters Studio     Duration: 02:13Published

Johnson & Johnson working on vaccine for coronavirus [Video]Johnson & Johnson working on vaccine for coronavirus

As the death toll from the new coronavirus jumped to 132, Johnson & Johnson said it is working on developing a vaccine to stop the outbreak that has infected thousands in China. Colette Luke reports

Credit: Reuters Studio     Duration: 00:53Published

Johnson & Johnson misses revenue estimates [Video]Johnson & Johnson misses revenue estimates

Johnson & Johnson on Wednesday posted a rare miss on quarterly revenue as sales of some of its major drugs fell short of Wall Street expectations. Yahaira Jacquez reports.

Credit: Reuters Studio     Duration: 00:57Published

 

Jury orders Johnson & Johnson to pay $750 million in New Jersey talc case

Johnson & Johnson was ordered on Thursday by a New Jersey state jury to pay punitive damages of $750 million to four plaintiffs who allege that the company's Baby Powder caused their cancer, a ruling..
Reuters - Published

U.S. government experts, industry spar over asbestos testing in talc

For the first time in nearly 50 years, the U.S. Food and Drug Administration examined asbestos testing for talc powders and cosmetics at a hearing on Tuesday, after traces of the known carcinogen were..
Reuters - Published

FDA holds rare public meeting on asbestos testing in talc

For the first time in nearly 50 years, the U.S. Food and Drug Administration examined asbestos testing for talc powders and cosmetics at a hearing on Tuesday, after traces of the known carcinogen were..
Reuters - Published

$8 Billion Verdict in Drug Lawsuit Is Reduced to $6.8 Million

A Philadelphia judge lowered the damages in a case that claimed Johnson & Johnson played down the risks of an antipsychotic drug.
NYTimes.com - Published

Here's how you can get money from a $6.3 million Infants' Tylenol settlement

Johnson & Johnson agreed to pay $6.3 million to settle a lawsuit over its packaging of Infants' Tylenol.
USATODAY.com - Published

Whoops. Judge Reduces J&J Opioid Fine After Mistaking Thousands for Millions

Johnson & Johnson will now have to pay $465 million, not $572 million, for its role in Oklahoma’s opioid epidemic.
NYTimes.com - Published

Oklahoma judge reduces Johnson & Johnson opioid payout to $465 million

An Oklahoma judge on Friday said Johnson & Johnson must pay that state $465 million for fueling the opioid epidemic through the deceptive marketing of painkillers, down from his original award of $572..
Reuters - Published

J&J says no asbestos in recalled baby power

Company has lost more than 8% of its market value amid concerns about its Baby Powder and the cancer-causing mineral
CBS News - Published

J&J says new tests find no asbestos in same baby powder bottle that sparked recall

Johnson & Johnson said on Tuesday that 15 new tests found no asbestos in a bottle of baby powder that the U.S. Food and Drug Administration says tested positive for trace amounts of asbestos, a finding..
Reuters - Published

Johnson & Johnson says new tests find no asbestos in FDA-tested baby powder

Johnson & Johnson said on Tuesday that 15 new tests from the same bottle of its baby powder previously tested by the U.S. Food and Drug Administration found no asbestos.
Reuters - Published

Walgreens, Target remove all 22-ounce J&J baby powder from their shelves

Walgreens Boots Alliance Inc and Target Corp on Friday became the latest retailers to remove all 22-ounce bottles of Johnson & Johnson baby powder from their stores, after the healthcare conglomerate..
Reuters - Published

MoneyWatch: Juul pulls flavors, J&J settlement, beer lawsuit

In today's MoneyWatch headlines, Juul pulls most flavored vape products from shelves, Johnson and Johnson agrees to a settlement over pelvic mesh, and the owner of Budweiser accuses MillerCoors of..
CBS News - Published

Johnson & Johnson recalls baby powder for asbestos

Consumer products giant said the recall is limited to a single batch made and shipped in the U.S. in 2018
CBS News - Published Also reported by •USATODAY.com

J&J agrees to $117M settlement over pelvic mesh devices

Thousands of women have come forward claiming the devices caused severe pain, bleeding and infections
CBS News - Published

Judge says he miscalculated award by $107M in J&J opioid case

Oklahoma court acknowledged it erroneously added three zeroes in calculating opioid ruling
CBS News - Published

Missouri appeals court overturns $110 million Johnson & Johnson talc verdict

A Missouri appeals court overturned a $110 million verdict against Johnson & Johnson in a lawsuit by a Virginia woman who says she developed ovarian cancer after decades of using of its talc-based..
Reuters - Published

Johnson & Johnson ordered to pay $8 billion to man who said drug caused him to grow breasts

Johnson & Johnson denounced the ruling. However, the drug company is facing thousands of cases over Risperdal's ties to breast growth.
USATODAY.com - Published

Johnson & Johnson hit with $8B verdict over drug linked to boy growing breasts

There's more legal trouble for Johnson & Johnson. A Philadelphia jury has ordered it to pay $8 billion in punitive damages in a case unrelated to lawsuits over its signature baby powder. The jury found..
CBS News - Published

Johnson & Johnson Hit With $8 Billion Jury Verdict in Risperdal Suit

A Philadelphia jury found that a subsidiary downplayed the risks that the anti-psychotic drug could lead to breast growth in boys.
NYTimes.com - Published

Johnson & Johnson settles landmark opioid case for $20.4 million

The deal comes less than three before the scheduled start of the first federal trial over the opioid crisis
CBS News - Published

Johnson & Johnson settles Ohio lawsuits to avoid federal trial

Johnson & Johnson said on Tuesday it will pay $20.4 million to settle claims by two Ohio counties, allowing the U.S. healthcare giant to avoid an upcoming federal trial seeking to hold the industry..
Reuters - Published

J&J to pay $20.4 million to settle opioid lawsuits with two Ohio counties

Johnson & Johnson said on Tuesday it will pay $20.4 million to settle claims by two Ohio counties in a lawsuit that accused the drugmaker of contributing to an U.S. opioid addiction epidemic.
Reuters - Published

J&J settles with Ohio counties ahead of opioid trial

Johnson & Johnson said on Tuesday it settled with two Ohio counties, ahead of an opioid trial scheduled to begin on Oct. 21.
Reuters - Published

Johnson & Johnson calls judge's ruling "flawed," plans to appeal $572 million ruling in opioid trial

An Oklahoma judge ruled Monday that Johnson & Johnson's misleading marketing led to addictions and deadly overdoses of opioids. The consumer products giant plans to appeal the $572 million verdict...
CBS News - Published

Drugmakers' liability for opioid crisis could reach $150 billion

Analysts say the $572 million ruling against Johnson & Johnson sets a benchmark for pending federal and state suits
CBS News - Published

With Johnson & Johnson ruling in Oklahoma, opioid reckoning finally starts taking shape

I testified at the Oklahoma opioid trial and welcome the verdict. Now we need to treat everyone in need, educate America and end this health crisis.
USATODAY.com - Published

Johnson & Johnson’s Brand Falters Over Its Role in the Opioid Crisis

An Oklahoma court case highlights the health care giant’s role in the epidemic as a leading supplier of opioid ingredients.
NYTimes.com - Published

Opioid trial decision could shape other cases

Oklahoma's court fight against Johnson & Johnson and it subsidiaries could be a road map for other states to follow in holding drugmakers responsible for the opioid crisis. (Aug. 27)  
USATODAY.com - Published

What risks lie ahead for Johnson & Johnson after $572M opioid ruling?

Johnson & Johnson faces potentially significant liability for its role in the opioid crisis.
USATODAY.com - Published

8/27: CBSN AM

Johnson & Johnson to pay $572M in landmark opioid trial; Families transformed by gun violence
CBS News - Published

What to expect after the Oklahoma Johnson & Johnson ruling

The $572 million judgment against Johnson & Johnson may be followed by more trials and legal settlements
CBS News - Published

Oklahoma's $572 million opioid judgment against Johnson & Johnson: Here's what comes next

The $572 million judgement against Johnson & Johnson won't be the last time a trial looks to hold a drug company accountable for the opioid crisis.
USATODAY.com - Published

Oklahoma AG on the "shameful stream of commerce" that led to the opioid crisis

In a first-of-its-kind case, a judge is punishing Johnson & Johnson for its role in the opioid crisis. A judge ordered the health care giant to pay $572 million dollars to Oklahoma. He ruled that the..
CBS News - Published

Eye Opener: A landmark ruling against Johnson & Johnson

Johnson & Johnson is ordered to pay $572 million in a groundbreaking verdict. Also, the governor of Puerto Rico declares a state of emergency in anticipation of Tropical Storm Dorian. All that and all..
CBS News - Published

AP Top Stories August 27

Here's the latest for Tuesday August 27th: Judge rules against Johnson & Johnson in opioids case; Tropical storm approaches Caribbean; White House clarifies President Trump's statements on Kim Jong Un;..
USATODAY.com - Published

Judge finds Johnson & Johnson guilty in Oklahoma opioid case, calls for $527 million payment

In a landmark ruling on Monday, an Oklahoma judge found Johnson and Johnson guilty of helping to fuel the state's opioid crisis. The company was ordered to pay over $500 million to help address the..
CBS News - Published

8/26: CBS Evening News

Johnson & Johnson ordered to pay Oklahoma $572 million for fueling opioid crisis; Tennis trailblazer Althea Gibson honored on first day of U.S. Open.
CBS News - Published

Johnson & Johnson ordered by judge to pay over $572 million for role in opioid crisis

Oklahoma lawyers argued Johnson & Johnson aggressively marketed opioids that overstated their effectiveness and underplayed the addiction risk.  
USATODAY.com - Published Also reported by •CBS News

J&J say they will fight Oklahoma opioid ruling

An Oklahoma judge found Johnson & Johnson and its subsidiaries helped fuel the state's opioid crisis and ordered the them to pay $572 million, more than twice the amount another drug manufacturer..
USATODAY.com - Published

J&J liable for $572 million in Oklahoma opioid epidemic trial, shares rise

An Oklahoma judge on Monday ordered Johnson & Johnson to pay $572.1 million to the state for its part in fueling an opioid epidemic by deceptively marketing addictive painkillers.
Reuters - Published

G7, Amazon, Johnson & Johnson: Your Monday Evening Briefing

Here’s what you need to know at the end of the day.
NYTimes.com - Published

You Might Like


 Page 1  〉 
Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2020 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.